Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Genetic Testing Advisory Committee To Include Device, CLIA Panel Reps

This article was originally published in The Gray Sheet

Executive Summary

HHS' planned Advisory Committee on Genetic Testing will include at least one active member of FDA's Medical Devices Advisory Committee and the Clinical Laboratory Improvement Advisory Committee, according to the group's charter.

You may also be interested in...



Genetic Testing Oversight Public Input Sought By HHS Advisory Panel

HHS' Advisory Committee on Genetic Testing will solicit public input at a Jan. 27 meeting to help determine an appropriate mechanism for the collection and analysis of data on the analytical validity, clinical validity and clinical utility of genetics tests, panel members agreed at their Oct. 26 meeting.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

UsernamePublicRestriction

Register

MT010501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel